Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -11.95x is 99% above its 2-year average of -809.17x, near the high end of its 2-year range (-2568.33x–-11.95x).
As of the fiscal period ended Friday, March 31, 2023. 97.28% above its 12-month average of -439.60x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -11.95x.
INTEREST COVERAGE RATIO
-11.95x
INTEREST COVERAGE RATIO AVG TTM
-439.60x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+97.28%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-115.75%
vs the sector median at left
Pulse Biosciences, Inc.
Market Cap
$3.43B
Interest Coverage Ratio
-11.95x
TTM Avg
-439.60x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.43B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
Market Cap
$3.37B
Interest Coverage Ratio
-99.92x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Interest Coverage Ratio
-2.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.61B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.14B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.43B | -11.95x | -439.60x | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | N/A | 407.95x | 407.95x | 407.95x |
| CareDx, Inc (CDNA)vs › | $3.45B | N/A | 0.59x | 0.59x | 0.59x |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.37B | -99.92x | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -2.80x | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.54B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.54B | -10.04x | N/A | N/A | N/A |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.61B | N/A | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.14B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | -1.01x | N/A | N/A | N/A |
Interest Coverage
-12.0x
Debt/Equity
0.07
Current Ratio
9.63
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -11.95x |
| 2022-12-31 | -19.35x |
| 2022-09-30 | -1287.50x |
| 2021-12-31 | -2568.33x |
| 2021-09-30 | -1585.89x |
| 2021-06-30 | -28.64x |
| 2021-03-31 | -162.50x |
